| Date | Form | Description | Docs | XBRL | Pages |
| 03/17/11 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
52 | |
| 09/14/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
58 | |
| 09/14/10 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
14 | |
| 06/14/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
58 | |
| 03/17/10 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
47 | |
| 09/09/09 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
33 | |
| 06/18/09 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
30 | |
| 06/10/09 | NT 10-Q | Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB |
|
3 | |
| 03/12/09 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
28 | |
| 09/19/08 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
39 |
Latest News & Events
Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress
Read More...Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
Read More...